Trial Profile
The efficacy of natalizumab in patients with multiple sclerosis from the Hungarian natalizumab database
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 May 2014
Price :
$35
*
At a glance
- Drugs Natalizumab (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 15 May 2014 New trial record